Phoenix Local Business
Friday, October 23, 2015
FDA Approves New Option for Soft-Tissue Sarcoma
(MedPage Today) -- Trabectedin slowed disease progression versus dacarbazine
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment